FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 212 filers reported holding FIBROGEN INC in Q3 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $105,343,000 | -23.3% | 3,955,787 | 0.0% | 1.08% | -20.1% |
| Q1 2021 | $137,305,000 | -6.4% | 3,955,787 | 0.0% | 1.36% | +16.4% |
| Q4 2020 | $146,720,000 | -9.8% | 3,955,787 | 0.0% | 1.17% | -5.4% |
| Q3 2020 | $162,662,000 | +1.5% | 3,955,787 | 0.0% | 1.23% | -16.0% |
| Q2 2020 | $160,328,000 | +16.6% | 3,955,787 | 0.0% | 1.47% | -20.9% |
| Q1 2020 | $137,464,000 | -19.0% | 3,955,787 | 0.0% | 1.85% | -12.3% |
| Q4 2019 | $169,664,000 | +31.0% | 3,955,787 | +12.9% | 2.11% | +18.7% |
| Q3 2019 | $129,552,000 | +5.2% | 3,503,287 | +28.6% | 1.78% | -35.3% |
| Q2 2019 | $123,094,000 | +13.1% | 2,724,519 | +36.0% | 2.75% | -9.2% |
| Q1 2019 | $108,879,000 | +17.4% | 2,003,287 | 0.0% | 3.03% | -21.1% |
| Q4 2018 | $92,712,000 | – | 2,003,287 | – | 3.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 605,713 | $9,703,522 | 5.73% |
| ARMISTICE CAPITAL, LLC | 3,864,000 | $61,901,280 | 1.08% |
| Logos Global Management LP | 525,000 | $8,410,500 | 0.98% |
| 5AM Venture Management, LLC | 225,583 | $3,613,840 | 0.97% |
| Intercontinental Wealth Advisors, LLC | 191,300 | $3,064,626 | 0.91% |
| BHK Investment Advisors, LLC | 87,550 | $1,402,551 | 0.79% |
| Integral Health Asset Management, LLC | 175,000 | $2,803,500 | 0.59% |
| Nan Fung Group Holdings Ltd | 34,106 | $546,378 | 0.38% |
| Soleus Capital Management, L.P. | 113,463 | $1,817,677 | 0.26% |
| Point72 Asset Management, L.P. | 4,781,645 | $76,601,953 | 0.26% |